• 대한화학회지
• /
• 제47권1호
• /
• pp.26-30
• /
• 2003

이핵 화합물, $Ag_2$[Phen]_2[S_2P(OPr)_2]_2$(Phen=1,10-phenanthroline; Pr=propyl)은 비스(디프로필디싸이오포스페이토) 은(|)화합물과 1,10 펜안트로린 리간드 반응에 의하여 합성되었고, 그 화합물 구조는 X-ray에 의하여 규명되었다. 두 디프로필디싸이오포스페이토 리간드는 두 개의 은 원자를 연결하여 팔각형 $Ag_2S_4P_2$ 고리를 형성하였고, 1,10-펜안트로린 리간드는 은 이온과 결합하여 사면체구조를 이루었다. Ag-S 결합거리는 2.471(1)와 2.567(1) ${\AA}$이었고, Ag-N 결합 거리는 2.3666(3)와 2.471(3) ${\AA}$이었다.

• 대한환경공학회지
• /
• 제38권9호
• /
• pp.469-475
• /
• 2016

본 연구는 실제 운영되는 수산물 가공 산업폐수의 immersed MBR (iMBR)공정을 이용한 폐수처리시설 운영 결과에 대한 실증적 고찰을 수행한 것이다. 수산물 가공 산업의 특성상 일별, 월별 유량 변동이 심하여 유량조정조의 설계 및 운전방법이 중요하며, 유량조정조 교반시 포기식 교반을 적용하면 산발효 방지를 통하여 후속 응집/부상 공정의 약품비 절감이 가능하다. 동 현장은 유량조정조, 가압부상조, iMBR을 거쳐 방류하며, 이때 가압부상조를 거쳐 iMBR로 유입되는 BOD, $COD_{Mn}$, SS, T-N, T-P의 농도는 2,291 mg/L, 530 mg/L, 38 mg/L, 256.8 mg/L, 13.5 mg/L으로 나타났다. 수산물 가공 폐수와 같이 고농도의 염이 함유된 폐수의 생물학적 처리는 슬러지의 침강성과 관계없는 침지식 중공사막을 이용한 iMBR 공법을 적용하는것이 바람직한 것으로 나타났다. iMBR 공정의 주요 에너지 소모 요인인 공기세정에 대한 운영 값의 검토 결과 SADm값이 $0.31m^3/hr{\cdot}m^2$ membrane area이었으며, SADp값은 $26.5m^3/hr{\cdot}m^3$ permeate으로 상용화된 평막 대비 월등히 에너지 효율이 우수한 것으로 나타났다. 무산소, 혐기, 호기 탈기조로 구성된 침지식 중공사막이 결합된 iMBR 공정에서 막오염 지표인 Normalized TMP와 온도, MLSS 등을 비교 분석한 결과 F/M비가 0.08~0.10 gBOD/gMLSS에서 임계 F/M 값을 나타냈다. 생물반응조에서의 BOD, $COD_{Mn}$, SS, T-N, T-P의 처리수질은 각각 1.8 mg/L, 11.0 mg/L, 1.1 mg/L, 11.0 mg/L, 0.24 mg/L으로 운전되었으며, 제거율은 99.9%, 97.9%, 96.3%, 95.7%, 97.8%으로 나타났다.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제26권4호
• /
• pp.414-421
• /
• 2000

The objective evaluation of velopharyngeal closure function is the key to diagnosis and therapy control of velopharyngeal incompetency. The aim of this study is to evaluate the aerodynamic and acoustic characteristics of the velopharyngeal closure function of patients who have developed velopharyngeal incompetency after management with speech aids. The test words were composed of sustained vowels /a/, /i/, /e/, /u/, /ja/, /je/, /wi/ and polysyllabic words /p'ap'i/, /siso/, /mami/ for measuring nasalance, The data was collected before the placement of the speech aids and one to three months after. The results were as follows: The nasalance score of the velopharyngeal incompetency speakers was higher than that of the normal control group, except for nasal sounds, and was decreased after placement of the speech aids, especially in high vowels /i/ (P<.01) and /wi/ (P<.05).

• Clinical and Experimental Reproductive Medicine
• /
• 제24권2호
• /
• pp.211-216
• /
• 1997

본 연구는 Vero cell을 이용한 사람 배아의 공동배양술이 배아의 질을 향상시킬 수 있거나 또는 반복적 착상 실패를 극복하여 임신을 가능케 할 수 있는지 알아 보고자 시행되었다. 1996년 일년 동안, 반복적 착상 실패를 경험한 환자 (group I)와 이전 주기에서 배아의 질이 나빴던 환자 (group II)를 포함한 총 202례를 분석하여 대조군과 공동배양군 간의 배아의 질, 임신률, 임신유지율 및 착상률을 비교하였다. Group I 93례 가운데 34례는 공동배양을, 나머지 59례는 기존의 체외수정을 시행하였다. Group II 109례에서는 공동배양 36례, 기존의 체외수정 73례를 시행하였다. Group I에서 공동배양군의 임신률, 임신유지율 및 착상률은 각각 14/34 (41.2%), 9/34 (26.5%), 16/81 (19.8%)로 대조군 (11/59 (18.6%), 8/59 (13.6%), 12/152 (7.9%))에 비하여 높았으며, 특히 임신률과 착상률은 유의한 차이를 나타내었다(p=0.028, p=0.015). Group II에서는 공동배양군의 임신률과 임신유지율 및 착상률이 각각 8/36 (22.2%), 5/36 (13.9%), 8/87 (9.2%)로 대조군 (5/73 (6.8%), 3/73 (4.1%), 3/158 (1.9%))에 비하여 높았고, group I의 결과에서와 마찬가지로 임신률과 착상률의 유의한 차이를 나타내었다(p=0.028, p=0.022). 이상에서 Vero cell을 이용한 공동배양술은 위의 두가지 주소를 가진 환자군에서 좋은 결과를 나타내었다. 또한 group II에서 3일-공동배양군의 임신률 역시 향상되어 (4/15 (26.7%)), 보조부화술을 겸비한 3일-공동배양이 이전 주기에서 배아의 질이 나빴던 환자군에 적용될 수 있음을 알 수 있었다. 결론적으로 Vero cell을 이용한 공동배양술은 반복적 착상 실패를 경험한 환자나 또는 이전 주기에서 배아의 질이 나빴던 환자에게 적용하여 임신률을 향상시킬 수 있을 것으로 사료된다.

• 대한두경부종양학회지
• /
• 제15권2호
• /
• pp.141-148
• /
• 1999

Objectives: The development of thyroid tumor has a relationship with carcinogen, oncogene and tumor suppressor gene. With aminotriazole, radioactive iodine and nitrosomethylurea as carcinogens in rat, authors investigate the incidence in type of the thyroid tumors, p21 and p53 protein expression pattern by immunohistochemical stain and the relationship between the tumors and p21-p53 protein expressions. Materials and Methods: 80 experimental animals were divided into four groups; group 1(control, no carcinogen, n=20), group 2(oral administration of aminotriazole for 36 weeks, n=20), group 3(intraperitoneal injection of 131I for one time and oral administration of aminotriazole for 36 weeks, n=20), group 4(oral administration of nitrosomethylurea for 3 days and aminotriazole for 36 weeks, n=20). After 40 weeks they were sacrificed with pathologic examination and we performed immunohistochemical staining with pan-ras monoclonal antibody for p21 protein and CMI polyclonal antibody for p53 protein with paraffin-embedded specimens. Results: 1) No tumors were observed in group I, but 38.3% of nodular goiters, 11.7% of adenomas and 50.0% of carcinomas were observed in carcinogen treated groups(group 2, 3, 4). 2) The incidence of nodular goiter, adenoma and carcinoma were 70%, 20% and 10% in group 2, 40%, 15% and 45% in group 3 and 5%, 0% and 95% in group 4. 3) p21 protein was not expressed in normal thyroid tissues but was expressed in 26.1% of nodular goiters, 42.9% of adenomas and 6.7% of carcinomas. On the other hands, p53 protein was not expressed in normal thyroid tissues, nodular goiters, adenomas and in well differentiated thyroid carcinomas by immunohistochemical stain. Conclusion: The authors suggest that aminotrizole, 131I, nitrosomethylurea can be etiologic agents in the development of thyroid tumor and the p21 protein can be expressed in the early stage and in benign condition of thyroid tumor but p53 protein is not expressed in all conditions of development in rats.

• Journal of Pharmaceutical Investigation
• /
• 제40권5호
• /
• pp.291-296
• /
• 2010

This study was to investigate the effect of baicalein, an antioxidant, on the bioavailability of nicardipine after orally or intravenously administered nicardipine in rats. Nicardipine was administered orally (12 mg/kg) or intravenously (4 mg/kg) with or without orally administered baicalein (0.4, 2 or 10 mg/kg) to rats. In the inhibitory effect of baicalein on CYP3A4 activity, baicalein inhibited CYP3A4 activity with $IC_{50}$ values of 9.2 ${\mu}M$. The cell-based P-gp activity test using rhodamine-123 also showed that baicalein (30-10 ${\mu}M$, p<0.01) significantly inhibited P-gp activity. Compared with the control group (given nicardipine alone), the area under the plasma concentration-time curve (AUC) was significantly (2 mg/kg, P<0.05; 10 mg/kg, P<0.01) increased by 25.9-60.0%, and the peak concentration ($C_{max}$) was significantly (10 mg/kg, P<0.01) increased by 40.0% in the presence of baicalein after orally administration of nicardipine. Consequently, the relative bioavailability (R.B.) of nicardipine was increased by 1.26- to 1.60-fold and the absolute bioavailability (A.B.) was significantly (2 mg/kg, P<0.05; 10 mg/kg, P<0.01) increased by 26.0-59.9%. Compared to the i.v. control, baicalein did not significantly change pharmacokinetic parameters of nicardipine in i.v. administration. Accordingly, the enhanced oral bioavailability of nicardipine might be mainly due to increased intestinal absorption caused by P-gp inhibition rather than to reduced elimination of nicardipine by baicalein. The increase in the oral bioavailability might be mainly attributed to enhanced absorption in the small intestine via the inhibition of P-gp and reduced first-pass metabolism of nicardipine via the inhibition of the CYP3A subfamily in the small intestine and/or in the liver by baicalein. Based on these results, nicardipine dosage should be adjusted when given concomitantly with baicalein.

• Nonlinear Functional Analysis and Applications
• /
• 제26권2호
• /
• pp.331-345
• /
• 2021

Let p(z)be a polynomial of degree n. Then Bernstein's inequality [12,18] is $${\max\limits_{{\mid}z{\mid}=1}}\;{\mid}p^{\prime}(z){\mid}\;{\leq}\;n\;{\max_{{\mid}z{\mid}=1}{\mid}(z){\mid}}$$. For q > 0, we denote $${\parallel}p{\parallel}_q=\{{\frac{1}{2{\pi}}}{\normalsize\displaystyle\smashmargin{2}{\int\nolimits_{0}}^{2{\pi}}}\;{\mid}p(e^{i{\theta}}){\mid}^qd{\theta}\}^{\frac{1}{q}}$$, and a well-known fact from analysis [17] gives $${{\lim_{q{\rightarrow}{{\infty}}}}\{{\frac{1}{2{\pi}}}{\normalsize\displaystyle\smashmargin{2}{\int\nolimits_{0}}^{2{\pi}}}\;{\mid}p(e^{i{\theta}}){\mid}^qd{\theta}\}^{\frac{1}{q}}={\max\limits_{{\mid}z{\mid}=1}}\;{\mid}p(z){\mid}$$. Above Bernstein's inequality was extended by Zygmund [19] into L^q norm by proving ║p'║_q ≤ n║p║_q, q ≥ 1. Let p(z) = a₀ + ∑ⁿ_𝜈=𝜇 a_𝜈z^𝜈, 1 ≤ 𝜇 ≤ n, be a polynomial of degree n having no zero in |z| < k, k ≥ 1. Then for 0 < r ≤ R ≤ k, Aziz and Zargar [4] proved $${\max\limits_{{\mid}z{\mid}=R}}\;{\mid}p^{\prime}(z){\mid}\;{\leq}\;{\frac{nR^{{\mu}-1}(R^{\mu}+k^{\mu})^{{\frac{n}{\mu}}-1}}{(r^{\mu}+k^{\mu})^{\frac{n}{\mu}}}\;{\max\limits_{{\mid}z{\mid}=r}}\;{\mid}p(z){\mid}}$$. In this paper, we obtain the L^q version of the above inequality for q > 0. Further, we extend a result of Aziz and Shah [3] into L^q analogue for q > 0. Our results not only extend some known polynomial inequalities, but also reduce to some interesting results as particular cases.

• Radiation Oncology Journal
• /
• 제29권3호
• /
• pp.199-205
• /
• 2011

Purpose: The present study compared the difference between intraoperative transrectal ultrasound (iTRUS)-based prostate volume and preplan computed tomography (CT), preplan magnetic resonance imaging (MRI)-based prostate volume to estimate the number of seeds needed for appropriate dose coverage in permanent brachytherapy for prostate cancer. Materials and Methods: Between March 2007 and March 2011, among 112 patients who underwent permanent brachytherapy with $^{125}I$, 60 image scans of 56 patients who underwent preplan CT (pCT) or preplan MRI (pMRI) within 2 months before brachytherapy were retrospectively reviewed. Twenty-four cases among 30 cases with pCT and 26 cases among 30 cases with pMRI received neoadjuvant hormone therapy (NHT). In 34 cases, NHT started after acquisition of preplan image. The median duration of NHT after preplan image acquisition was 17 and 21 days for cases with pCT and pMRI, respectively. The prostate volume calculated by different modalities was compared. And retrospective planning with iTRUS image was performed to estimate the number of $^{125}I$ seed required to obtain recommended dose distribution according to prostate volume. Results: The mean difference in prostate volume was 9.05 mL between the pCT and iTRUS and 6.84 mL between the pMRI and iTRUS. The prostate volume was roughly overestimated by 1.36 times with pCT and by 1.33 times with pMRI. For 34 cases which received NHT after image acquisition, the prostate volume was roughly overestimated by 1.45 times with pCT and by 1.37 times with pMRI. A statistically significant difference was found between preplan image-based volume and iTRUS-based volume (p<0.001). The median number of wasted seeds is approximately 13, when the pCT or pMRI volume was accepted without modification to assess the required number of seeds for brachytherapy. Conclusion: pCT-based volume and pMRI-based volume tended to overestimate prostate volume in comparison to iTRUS-based volume. To reduce wasted seeds and cost of the brachytherapy, we should take the volume discrepancy into account when we estimate the number of $^{125}I$ seeds for permanent brachytherapy.

• Journal of Yeungnam Medical Science
• /
• 제17권1호
• /
• pp.75-81
• /
• 2000

저자들은 후향적 연구로 1995년 1월부터 1999년 3월까지 영남대학교 의과대학 부속병원에 내원하여 경흉부 및 경식도 심초음파를 시행한 승모판 협착증 환자 중 1년 이상 경과 관찰된 127명의 환자를 대상으로 뇌경색의 예측인자를 알아봄으로써 향후 예방 및 치료에 도움을 주고자 본 연구를 시행하였다. 전체 127명의 대상군은 뇌경색이 발생한 군(Group I; n=26, 나이: $55.0{\pm}13$세)과 뇌경색이 발생하지 않은 군(Group II: n=101, 나이: $48.5{\pm}13$)으로 나누었으며, 두구간에 성별이나 심부전의 정도(NYHA functional class)에는 의미있는 차이가 없었다. 뇌경색군(Goup I)에서 나이가 많았으며($55.0{\pm}13$ vs $48.5{\pm}13$;p<0.05) 좌심방 크기가 보다 컸으며($5.10{\pm}0.48$ vs $4.81{\pm}0.70$;p<0.05), 승모판구 면적이 보다 작았고($1.01{\pm}0.39$ vs $1.21{\pm}0.45$:p<0.05), 심방세동의 유병률이 보다 높았다(22명/26명 vs 57명/101명;p<0.05). 좌심방의 자발에코 영상은 뇌경색군(22명/26명)에서 비뇌경색군(44명/101명)보다 더 많이 관찰되었다(p<0.001). 상기 의미있는 변수들을 Multivariate logistic regression 분석결과 통계학적으로 유의한 예측인자는 심방세동(R.R=7.69)과 항응고제 치료(R.R=0.23)이었다. 결론적으로, 승모판 협착증 환자에서 뇌경색 발생과 연관된 유의한 예측인자는 심방세동과 항응고제 치료였으며, 나이와 좌심방 크기, 승모판구 면적, 좌심방의 자발에코영상도 밀접한 관계가 있었다. 따라서 심방세동을 동반한 고연령의 중증 승모판 협착증 환자에서는 조기 항응고제 투여가 전신색전증 예방에 주요할 것으로 사료된다.

• Bulletin of the Korean Chemical Society
• /
• 제33권6호
• /
• pp.1885-1889
• /
• 2012

Among 23 cytochrome P450s, CYP125A4 was proposed as a putative monooxygenase based on the high level of amino acid sequence homology (54% identity and 75% similarity) with the well characterized C27-steroid $Mycobacterium$ $tuberculosis$ CYP125A1. Utilizing MTBCYP125A1 as a template, homology modeling of SPCYP125A4 was conducted by Accelrys Discovery Studio 3.1 software. The modeled SPCYP125A4 structure with lowest energy value was subsequently assessed for its stereochemical quality and side-chain environment. The final model was generated by showing its active site through the molecular dynamics. The docking of steroids showed broad specificity of SPCYP125A4 with different orientation of ligand within active site facing the heme. One poses of C27-steroid with C26 facing the heme with distance of 3.734 ${\AA}$ from the Fe were predominant.